7-Ethynyl-dA-CEP, ≥90%, 100 mg, emballage plastique.

Methyl 4-bromo-3,5-dihydroxybenzoate, 95.0%, 250mg

Fmoc-R-3-amino-4-(3,4-difluorophenyl)-butyric acid, 97%, 5g

3-Fluoro-4-hydroxybenzaldehyde, 98.0%, 1g

(R)-3-Amino-3-(4-methoxyphenyl)propanoic acid, 97%, 5g

Ethyl 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine-2-carboxylate;hydrochloride, 98+%, 1g

Methyl 2-(bromomethyl)-5-cyanobenzoate, 95.0%, 10g

4-CHLORO-2-METHOXY-6-NITROANILINE, 95.0%, 10g

6-Chloro-3-indolyl-beta-D-glucopyranoside, 98%, 1g

5-Bromo-N,N-dimethylpyridin-2-amine, 95.0%, 25g

3-[(DIPHENYLMETHYLENE)AMINO]DIHYDROFURAN-2(3H)-ONE, 95.0%, 1g

5-Bromo-2-methoxyphenylboronic acid, 95.0%, 25g

4-(O-tolyl)butanoic acid, 98+%, 1g